We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Assessment of C-reactive protein levels as an indicator for lung infiltrates in patients with COVID-19 pneumonia.
- Authors
Atef, Moaz; Eid, Hoda; Amin, Mohammad; Shehata, Mohamad; Shaarawy, Ahmed; Nabawy, Osama; Wahba, Ahmed; Aboseif, Ahmed; Rakha, Mohamed; Zaki, Mohamed; Mohammed, Eid; Albalsha, Abdullah; Nour, Sameh; Rezk, Amr; Shaheen, Mohamed; Kabil, Ahmed
- Abstract
Lung infiltrates are frequently observed in patients with COVID-19 infection and require specialized management. Identifying reliable laboratory parameters to reduce the need for chest CT scans in non-desaturation patients is of great interest. This study aimed to investigate the potential of C-reactive protein (CRP) as an indicator to identify the presence of lung infiltrates in early COVID-19 infection. The study was conducted at Al-Azhar University hospitals from May 2021 to March 2022 and included 210 patients with COVID-19 infection confirmed by positive PCR, all of whom were previously healthy, non-smokers, and non-hypoxemic. CRP levels were assessed and correlated with lung infiltrates observed in CT chest examinations. The mean value of CRP was 40.3±14.3 mg/L in males and 36.6±15.2 mg/L among females. One hundred sixty-two patients had pneumonic infiltrates, while 48 had no infiltrates. The mean value of CRP was 45.02±10.2 mg/L in patients with radiological infiltrates and 18.8±7.8 mg/L in patients without radiological infiltrates. Based on our findings, a CRP value greater than 29.8 mg/L was suggested as a cut-off value to indicate the presence of lung infiltrates. CRP is a simple laboratory marker that, at certain limits, may point to the presence of pneumonic infiltrates in early non-hypoxemic patients with COVID-19 infection.
- Publication
Journal of Medicine & Life, 2023, Vol 16, Issue 7, p1028
- ISSN
1844-122X
- Publication type
Article
- DOI
10.25122/jml-2023-0104